ArticleJournal of clinical medicine2026

Elranatamab in Relapsed/Refractory Multiple Myeloma: A Multicenter Real-World Study from Türkiye.

Aslı Bozdemir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.